The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 5396 -5404
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, W.
Right arrow Articles by Blazar, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, W.
Right arrow Articles by Blazar, B. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-TRYPTOPHAN

The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation1

Wei Chen2,*, Xueqing Liang*, Amanda J. Peterson*, David H. Munn{dagger} and Bruce R. Blazar*

* Division of Hematology-Oncology, Blood and Marrow Transplantation, Department of Pediatrics and The Cancer Center, University of Minnesota Medical School, Minneapolis, MN 55455; and {dagger} Department of Pediatrics and Immunotherapy Program, Medical College of Georgia, Augusta, GA 30912

Human plasmacytoid dendritic cells (PDCs) can drive naive, allogeneic CD4+CD25 T cells to differentiate into CD4+CD25+Foxp3+ regulatory T cells (Tregs). However, the intracellular mechanism or mechanisms underlying PDC-induced Treg generation are unknown. In this study, we show that human PDCs express high levels of IDO, an intracellular enzyme that catabolizes tryptophan degradation. Triggering of TLR 9 with CpG oligodeoxynucleotides activates PDCs to up-regulate surface expression of B7 ligands and HLA-DR Ag, but also significantly increases the expression of IDO and results in the generation of inducible Tregs from CD4+CD25 T cells with potent suppressor cell function. Blocking IDO activity with the pharmacologic inhibitor 1-methyl-D-tryptophan significantly abrogates PDC-driven inducible Treg generation and suppressor cell function. Adding kynurenine, the immediate downstream metabolite of tryptophan, bypasses the 1-methyl-D-tryptophan effect and restores PDC-driven Treg generation. Our results demonstrate that the IDO pathway is essential for PDC-driven Treg generation from CD4+CD25 T cells and implicate the generation of kynurenine pathway metabolites as the critical mediator of this process.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by research Grants from the Randy Shaver Cancer Research Community Fund and the Children’s Cancer Research Fund (to W.C.) and by National Institutes of Health Grants R01AI34495, 2R37HL56067, and P01 AI056299 (to B.R.B.) and R01CA103320, R01CA096651, and R01CA112431 (to D.H.M.).

2 Address correspondence and reprint requests to Dr. Wei Chen, University of Minnesota Cancer Center, Mayo Mail Code 806, 420 Delaware Street Southeast, Minneapolis, MN 55455. E-mail address: chenw{at}umn.edu

3 Abbreviations used in this paper: PDC, plasmacytoid dendritic cell; DC, dendritic cell; Foxp3, Forkhead box p3 transcriptional repressor; KYN, kynurenine; MFI, mean fluorescence intensity; 1MT, 1-methyl-D-tryptophan; ODN, oligodeoxynucleotide; Treg, regulatory T cell; Trp, tryptophan.




This article has been cited by other articles:


Home page
J. Immunol.Home page
F. Fallarino, C. Volpi, T. Zelante, C. Vacca, M. Calvitti, M. C. Fioretti, P. Puccetti, L. Romani, and U. Grohmann
IDO Mediates TLR9-Driven Protection from Experimental Autoimmune Diabetes
J. Immunol., November 15, 2009; 183(10): 6303 - 6312.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Jurgens, U. Hainz, D. Fuchs, T. Felzmann, and A. Heitger
Interferon-{gamma}-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells
Blood, October 8, 2009; 114(15): 3235 - 3243.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. R. Guerin, J. R. Prins, and S. A. Robertson
Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?
Hum. Reprod. Update, September 1, 2009; 15(5): 517 - 535.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. J. Chung, M. Rossi, E. Romano, J. Ghith, J. Yuan, D. H. Munn, and J. W. Young
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
Blood, July 16, 2009; 114(3): 555 - 563.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Kool, M. van Nimwegen, M. A. M. Willart, F. Muskens, L. Boon, J. J. Smit, A. Coyle, B. E. Clausen, H. C. Hoogsteden, B. N. Lambrecht, et al.
An Anti-Inflammatory Role for Plasmacytoid Dendritic Cells in Allergic Airway Inflammation
J. Immunol., July 15, 2009; 183(2): 1074 - 1082.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Brenk, M. Scheler, S. Koch, J. Neumann, O. Takikawa, G. Hacker, T. Bieber, and D. von Bubnoff
Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells
J. Immunol., July 1, 2009; 183(1): 145 - 154.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Bourreau, C. Ronet, E. Darcissac, M. C. Lise, D. Sainte Marie, E. Clity, F. Tacchini-Cottier, P. Couppie, and P. Launois
Intralesional Regulatory T-Cell Suppressive Function during Human Acute and Chronic Cutaneous Leishmaniasis Due to Leishmania guyanensis
Infect. Immun., April 1, 2009; 77(4): 1465 - 1474.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.